Decursin enhanced caspase-9-mediated apoptosis in doxorubicin-treated multiple myeloma cells, via the mTOR and STAT3 pathways [47] and other reports showed that decursin increased caspase-8-mediated apoptosis by increasing TRAIL sensitivity [49]. The gene discussed is STAT3; the disease is plasma cell myeloma.